Is CA 19-9 useful in the management of pancreatic cancer?

PubWeight™: 0.78‹?›

🔗 View Article (PMID 18237847)

Published in Lancet Oncol on February 01, 2008

Authors

Gianpaolo Balzano, Valerio Di Carlo

Articles by these authors

Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med (2011) 3.59

Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg (2002) 2.50

Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. Lancet Oncol (2005) 2.18

A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology (2002) 2.05

Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study. Int J Radiat Oncol Biol Phys (2013) 2.04

Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol (2003) 1.85

Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes (2002) 1.84

Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma. Cancer (2009) 1.82

Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol (2008) 1.81

Laparoscopic vs. open colectomy in cancer patients: long-term complications, quality of life, and survival. Dis Colon Rectum (2005) 1.79

Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Dis Colon Rectum (2007) 1.65

Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg (2012) 1.58

Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg (2002) 1.57

Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr (2007) 1.48

Laparoscopic versus open colorectal surgery: cost-benefit analysis in a single-center randomized trial. Ann Surg (2005) 1.47

The unsolved problem of fistula after left pancreatectomy: the benefit of cautious drain management. J Gastrointest Surg (2005) 1.37

FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J (2012) 1.35

The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res (2003) 1.32

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res (2008) 1.30

A prognostic score to predict major complications after pancreaticoduodenectomy. Ann Surg (2011) 1.29

Occlusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial. Ann Surg (2002) 1.26

Benefits of laparoscopic colorectal resection are more pronounced in elderly patients. Dis Colon Rectum (2008) 1.25

Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene (2002) 1.22

Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital. J Gastrointest Surg (2011) 1.21

Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients. J Immunol (2008) 1.18

Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg (2008) 1.18

Metabolic and functional results after laparoscopic colorectal surgery: a randomized, controlled trial. Dis Colon Rectum (2002) 1.14

Consensus guidelines on severe acute pancreatitis. Dig Liver Dis (2015) 1.12

Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell. J Immunol (2004) 1.10

Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol (2010) 1.09

Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc (2012) 1.07

A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile. Virchows Arch (2004) 1.05

Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis (2010) 1.02

Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience. Radiother Oncol (2008) 1.00

Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients. PLoS One (2009) 1.00

[Diverticular disease of the colon: diagnosis and treatment. Consensus Conference, 5th National Congress of the Italian Society of Academic Surgeons]. Ann Ital Chir (2009) 1.00

Open right colectomy is still effective compared to laparoscopy: results of a randomized trial. Ann Surg (2007) 0.99

Autologous pancreatic islet transplantation in human bone marrow. Diabetes (2013) 0.97

Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care (2003) 0.97

Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US. Radiology (2004) 0.96

Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs. Nutrition (2005) 0.95

Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol (2010) 0.94

Laparoscopic colorectal surgery modifies risk factors for postoperative morbidity. Dis Colon Rectum (2004) 0.94

Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation (2003) 0.92

Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology (2007) 0.91

Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol (2003) 0.89

Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol (2013) 0.88

Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trial. Pancreatology (2006) 0.87

XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. Anticancer Res (2010) 0.87

Learning curve for laparoscopic distal pancreatectomy in a high-volume hospital. Updates Surg (2012) 0.87

Mir-23a and mir-125b regulate neural stem/progenitor cell proliferation by targeting Musashi1. RNA Biol (2014) 0.84

Minimal focal steatosis of liver after islet transplantation in humans: a long-term study. Cell Transplant (2005) 0.84

Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. Tumour Biol (2014) 0.83

Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients. AJR Am J Roentgenol (2004) 0.83

Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma. Oncology (2005) 0.83

Successful surgical salvage of pancreas allograft. Transplantation (2003) 0.82

Enhanced recovery after surgery pathway in patients undergoing pancreaticoduodenectomy. World J Surg (2014) 0.80

Oral preoperative antioxidants in pancreatic surgery: a double-blind, randomized, clinical trial. Nutrition (2011) 0.79

Intraductal papillary mucinous tumors of the pancreas: incidence, clinical findings and natural history. JOP (2005) 0.79

A report of six cases of familial papillary thyroid cancer. Eur J Surg Oncol (2003) 0.79

Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Ann Surg Oncol (2012) 0.79

Preoperative chemotherapy does not adversely affect pancreatic structure and short-term outcome after pancreatectomy. J Gastrointest Surg (2012) 0.79

A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation (2004) 0.79

Results of 100 consecutive laparoscopic distal pancreatectomies: postoperative outcome, cost-benefit analysis, and quality of life assessment. Surg Endosc (2014) 0.78

[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. Chir Ital (2005) 0.78

Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release. Transplantation (2004) 0.77

Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy. Hepatogastroenterology (2003) 0.77

L-arginine-induced vasodilation of the renal vasculature is preserved in uremic type 1 diabetic patients after kidney and pancreas but not after kidney-alone transplantation. Diabetes Care (2004) 0.77

Islet Volume and Indexes of β-Cell Function in Humans. Cell Transplant (2015) 0.75

Spleen-preserving distal pancreatectomy with excision of splenic artery and vein: a cautionary note. World J Surg (2007) 0.75

Surgical management of acute pancreatitis in Italy: lessons from a prospective multicentre study. HPB (Oxford) (2010) 0.75

Diabetes after pancreatic surgery: novel issues. Curr Diab Rep (2015) 0.75

Urological complications after simultaneous renal and pancreatic transplantation. Eur J Surg (2002) 0.75

Strategies for tumor immune escape. Drugs Today (Barc) (2003) 0.75

What is the role of pancreas units today? JOP (2006) 0.75

Gastrointestinal bleeding from enterically drained transplanted pancreas. Transpl Int (2005) 0.75

Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions. Radiol Med (2004) 0.75

Management and Outcomes of Pancreatic Resections Performed in High-Volume Referral and Low-Volume Community Hospitals Lead by Surgeons Who Shared the Same Mentor: The Importance of Training. Dig Surg (2017) 0.75

Successful endovascular treatment for gastroduodenal artery pseudoaneurysm with an arteriovenous fistula after pancreas transplantation. Transpl Int (2003) 0.75

Advantages and disadvantages of enteric versus bladder diversion in simultaneous kidney-pancreas transplantation. Chir Ital (2002) 0.75